Celemics's latest marketcap:
As of 07/05/2025, Celemics's market capitalization has reached $18.22 M. According to our data, Celemics is the 36940th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 18.22 M |
| Revenue (ttm) | 4.81 M |
| Net Income (ttm) | 7.57 M |
| Shares Out | 8.16 M |
| EPS (ttm) | 0.92 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/14/2025 |
Celemics's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | ₩18.22 M | -6.87% | 36940 |
| 12/30/2024 | ₩26.74 B | -22.58% | 34861 |
| 12/28/2023 | ₩34.53 B | -27.07% | 31979 |
| 12/29/2022 | ₩47.35 B | -62.21% | 28858 |
| 12/30/2021 | ₩125.32 B | -42.07% | 22795 |
| 12/30/2020 | ₩216.33 B | 16801 |
Company Profile
About Celemics, Inc.
Celemics, Inc. is a biotechnology company specializing in the design, manufacture, and distribution of sequencing kits. Headquartered in Seoul, South Korea, the company was established in 2010 and serves a variety of research and clinical applications.
Products
- Whole Exome Sequencing Panels – Comprehensive genomic analysis tools.
- NGS Target Enrichment Panels – Customized and ready-to-use panels for precise sequencing.
- Modular Accessories – Includes:
- Library preparation kits
- Double standard cDNA synthesis
- Hybridization enhancer
- Clean-up and streptavidin beads
- CeleNM beads
- Polymerase
Services
- CeleMics Analysis
- Whole Exome Sequencing
- Customized NGS Panels
- Sequencing & Bioinformatics
- Biopharma Solutions
- Custom NGS Assay Development
Applications
Celemics' products and services are utilized across diverse fields, including:
- Oncology & Liquid Biopsy
- Inherited Diseases & Pharmacogenomics
- Virus Research & Agrigenomics
- RNA Sequencing & Epigenetics
- Metagenomic Sequencing
- Antibody Discovery & Bioinformatics
The company continues to innovate in genomic research, providing advanced solutions for scientific and medical advancements.
Frequently Asked Questions
-
What is Celemics's (KOSDAQ-331920) current market cap?As of 07/05/2025, Celemics (including the parent company, if applicable) has an estimated market capitalization of $18.22 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Celemics (KOSDAQ-331920) rank globally by market cap?Celemics global market capitalization ranking is approximately 36940 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.